These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19879770

  • 1. Spectroscopic study on the interaction of celecoxib with human carbonic anhydrase II: thermodynamic characterization of the binding process.
    Mehrabi M, Ghobadi S, Khodarahmi R.
    J Photochem Photobiol B; 2009 Dec 02; 97(3):161-8. PubMed ID: 19879770
    [Abstract] [Full Text] [Related]

  • 2. Mechanistic investigation of sulfonamide ligands as human carbonic anhydrase II inhibitors.
    Alaei L, Khodarahmi R, Sheikh-Hasani V, Sheibani N, Moosavi-Movahedi AA.
    Int J Biol Macromol; 2018 Dec 02; 120(Pt A):1198-1207. PubMed ID: 30176324
    [Abstract] [Full Text] [Related]

  • 3. Appraisal of sildenafil binding on the structure and promiscuous esterase activity of native and histidine-modified forms of carbonic anhydrase II.
    Mahdiuni H, Bijari N, Varzandian M, Ghadami SA, Khazaei M, Nikbakht MR, Khodarahmi R.
    Biophys Chem; 2013 Dec 02; 175-176():1-16. PubMed ID: 23500601
    [Abstract] [Full Text] [Related]

  • 4. Spectroscopic and molecular modeling studies on binding of dorzolamide to bovine and human carbonic anhydrase II.
    Bijari N, Ghobadi S, Mahdiuni H, Khodarahmi R, Ghadami SA.
    Int J Biol Macromol; 2015 Sep 02; 80():189-99. PubMed ID: 26093313
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of intrinsic fluorescence of human carbonic anhydrase II upon topiramate binding: Some evidence for drug-induced molecular contraction of the protein.
    Ghobadi S, Ashrafi-Kooshk MR, Mahdiuni H, Khodarahmi R.
    Int J Biol Macromol; 2018 Mar 02; 108():240-249. PubMed ID: 29217181
    [Abstract] [Full Text] [Related]

  • 6. Spectroscopic characterization of furosemide binding to human carbonic anhydrase II.
    Ranjbar S, Ghobadi S, Khodarahmi R, Nemati H.
    Int J Biol Macromol; 2012 May 01; 50(4):910-7. PubMed ID: 22343084
    [Abstract] [Full Text] [Related]

  • 7. Reversible binding of celecoxib and valdecoxib with human serum albumin using fluorescence spectroscopic technique.
    Seedher N, Bhatia S.
    Pharmacol Res; 2006 Aug 01; 54(2):77-84. PubMed ID: 16600620
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A, Pedone C, D'Ambrosio K, Scozzafava A, De Simone G, Supuran CT.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):437-42. PubMed ID: 16290146
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of thermal reversibility and stability of human carbonic anhydrase II by mesoporous nanoparticles.
    Khatibi A, Ma'mani L, Khodarahmi R, Shafiee A, Maghami P, Ahmad F, Sheibani N, Moosavi-Movahedi AA.
    Int J Biol Macromol; 2015 Apr 15; 75():67-72. PubMed ID: 25600988
    [Abstract] [Full Text] [Related]

  • 10. Complexation of cox-2 inhibitors with bovine serum albumin: interaction mechanism.
    Seedher N, Bhatia S.
    Pharm Dev Technol; 2009 Apr 15; 14(4):343-9. PubMed ID: 19235548
    [Abstract] [Full Text] [Related]

  • 11. Facile synthesis and characterization of novel pyrazole-sulfonamides and their inhibition effects on human carbonic anhydrase isoenzymes.
    Balseven H, Mustafa İşgör M, Mert S, Alım Z, Beydemir S, Ok S, Kasımoğulları R.
    Bioorg Med Chem; 2013 Jan 01; 21(1):21-7. PubMed ID: 23218470
    [Abstract] [Full Text] [Related]

  • 12. Competitive inhibitory effects of acetazolamide upon interactions with bovine carbonic anhydrase II.
    Safarian S, Bagheri F, Moosavi-Movahedi AA, Amanlou M, Sheibani N.
    Protein J; 2007 Sep 01; 26(6):371-85. PubMed ID: 17587158
    [Abstract] [Full Text] [Related]

  • 13. Modified β-casein restores thermal reversibility of human carbonic anhydrase II: the salt bridge mechanism.
    Fallah-Bagheri A, Moosavi-Movahedi AA, Taghizadeh M, Khodarahmi R, Ma'mani L, Bijari N, Bohlooli M, Shafiee A, Sheibani N, Saboury AA.
    Biotechnol Appl Biochem; 2013 Sep 01; 60(3):298-304. PubMed ID: 23621563
    [Abstract] [Full Text] [Related]

  • 14. Molecular basis for the origin of differential spectral and binding profiles of dansylamide with human carbonic anhydrase I and II.
    Banerjee AL, Tobwala S, Ganguly B, Mallik S, Srivastava DK.
    Biochemistry; 2005 Mar 15; 44(10):3673-82. PubMed ID: 15751944
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT.
    J Am Chem Soc; 2006 Jun 28; 128(25):8329-35. PubMed ID: 16787097
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A, De Simone G, Menchise V, Pedone C, Casini A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1937-42. PubMed ID: 15780637
    [Abstract] [Full Text] [Related]

  • 18. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R, Agnello S, Ferro S, De Luca L, Vullo D, Brynda J, Mader P, Supuran CT, Chimirri A.
    J Med Chem; 2010 Mar 25; 53(6):2401-8. PubMed ID: 20170095
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.